Abstract
Interleukin-1 (IL-1) receptor antagonist (anakinra) has been shown effective in steroid-dependent pericarditis resistant to nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine. We sought to evaluate the efficacy of anakinra given early after presentation with acute pericarditis in a proof-
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
